Helicobacter pylori in First Nations and recent immigrant populations in Canada.
暂无分享,去创建一个
R. Hunt | K. Jacobson | C. Fallone | N. Jones | N. Chiba | K. Goodman | Alan Thompson
[1] G. Capellá,et al. Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain , 2011, The American Journal of Gastroenterology.
[2] C. Hassan,et al. Helicobacter pylori in immigrants: a “foreign” bacterium? , 2011, Internal and emergency medicine.
[3] A. Egloff,et al. Response to Combined Molecular Targeting: Defining the Role of P-STAT3 , 2011, Clinical Cancer Research.
[4] D. Graham,et al. Strategy for Eliminating Gastric Cancer in Japan , 2010, Helicobacter.
[5] H. Funahashi,et al. Strategies for gastric cancer in the modern era. , 2010, World journal of gastrointestinal oncology.
[6] C. O'Morain,et al. Treatment of Helicobacter pylori Infection 2010 , 2010, Helicobacter.
[7] R. Peek,et al. Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.
[8] Hong Lu,et al. High Efficacy of 14‐Day Triple Therapy‐Based, Bismuth‐Containing Quadruple Therapy for Initial Helicobacter pylori Eradication , 2010, Helicobacter.
[9] C. Streutker,et al. Retrospective clinico-pathologic review of gastric cancer in an inner city Canadian hospital. , 2010 .
[10] K. McColl. Clinical practice. Helicobacter pylori infection. , 2010, The New England journal of medicine.
[11] Hsiu‐Po Wang,et al. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design , 2010, Gut.
[12] P. Hotez. Neglected Infections of Poverty among the Indigenous Peoples of the Arctic , 2010, PLoS neglected tropical diseases.
[13] I. Choi,et al. Cost‐Effectiveness of Eradication of Helicobacter pylori in Gastric Cancer Survivors After Endoscopic Resection of Early Gastric Cancer , 2009, Helicobacter.
[14] J. Gisbert. Review: Second-line rescue therapy of Helicobacter pylori infection , 2009, Therapeutic advances in gastroenterology.
[15] Sm,et al. and Gastric Cancer , 2009 .
[16] D. Graham,et al. Meta-analysis: Four-Drug, Three-Antibiotic, Non-bismuth-Containing „Concomitant Therapy“ Versus Triple Therapy for Helicobacter pylori Eradication , 2009 .
[17] A. Corriveau,et al. Helicobacter pylori infection in Canada's arctic: searching for the solutions. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[18] C. O'Morain,et al. Treatment of Helicobacter pylori Infection , 2008, Helicobacter.
[19] David K. Espey,et al. Gastric cancer among American Indians and Alaska Natives in the United States, 1999–2004 , 2008, Cancer.
[20] LaTisha L. Marshall,et al. Lung cancer incidence among American Indians and Alaska Natives in the United States, 1999–2004 , 2008, Cancer.
[21] M. Asaka,et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial , 2008, The Lancet.
[22] N. Luo,et al. Cost effectiveness analysis of population-based serology screening and (13)C-Urea breath test for Helicobacter pylori to prevent gastric cancer: a markov model. , 2008, World journal of gastroenterology.
[23] R. Holman,et al. Epidemiology of hospitalizations associated with ulcers, gastric cancers, and Helicobacter pylori infection among American Indian and Alaska Native persons. , 2008, The American journal of tropical medicine and hygiene.
[24] D. Armstrong,et al. Low prevalence of Helicobacter pylori infection in Canadian children: a cross-sectional analysis. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[25] K. Jacobson,et al. Helicobacter pylori infection in Canadian and related Arctic Aboriginal populations. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[26] R. Hunt,et al. Asia–Pacific consensus guidelines on gastric cancer prevention , 2008, Journal of gastroenterology and hepatology.
[27] R. Tao,et al. Effects of H pylori infection on gap-junctional intercellular communication and proliferation of gastric epithelial cells in vitro. , 2007, World journal of gastroenterology.
[28] F. Bazzoli,et al. Meta-analysis: Duration of First-Line Proton-Pump InhibitorBased Triple Therapy for Helicobacter pylori Eradication , 2007, Annals of Internal Medicine.
[29] A. Boussioutas,et al. Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression , 2007, The Journal of pathology.
[30] N. Kreiger,et al. Helicobacter pylori infection in Ontario: prevalence and risk factors. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[31] M. Beller,et al. Helicobacter pylori infection among non-Native educators in Alaska , 2007, International journal of circumpolar health.
[32] T. Wang,et al. Inflammation, atrophy, and gastric cancer. , 2007, The Journal of clinical investigation.
[33] C. O'Morain,et al. Treatment of Helicobacter pylori Infection , 2006, Helicobacter.
[34] W. Chey,et al. Levofloxacin-Based Triple Therapy versus Bismuth-Based Quadruple Therapy for Persistent Helicobacter pylori Infection: A Meta-Analysis , 2006, The American Journal of Gastroenterology.
[35] M. Leinonen,et al. Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[36] J. Parsonnet,et al. Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area. , 2005, American journal of epidemiology.
[37] Y. Yamaji,et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study , 2005, Gut.
[38] R. Hunt. Will eradication of Helicobacter pylori infection influence the risk of gastric cancer? , 2004, The American journal of medicine.
[39] K. Krogfelt,et al. Helicobacter pylori infection in Greenlandic patients with dyspepsia , 2004, International journal of circumpolar health.
[40] R. Hunt,et al. Helicobacter pylori and the prevention of gastric cancer. , 2004, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[41] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[42] M. Stolte,et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series , 2003, Gut.
[43] A. Barkun,et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study , 2003, Alimentary pharmacology & therapeutics.
[44] R. Hunt,et al. Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: A Prospective, Randomized, Multicenter, North A , 2003, American Journal of Gastroenterology.
[45] C. Bernstein,et al. Age at Acquisition of Helicobacter pylori in a Pediatric Canadian First Nations Population , 2002, Helicobacter.
[46] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[47] B. Swaminathan,et al. High Prevalence of Helicobacter pylori in the Alaska Native Population and Association with Low Serum Ferritin Levels in Young Adults , 2000, Clinical Diagnostic Laboratory Immunology.
[48] J. Everhart. Recent developments in the epidemiology of Helicobacter pylori. , 2000, Gastroenterology clinics of North America.
[49] J. Everhart,et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. , 2000, The Journal of infectious diseases.
[50] B. Molnár,et al. Increased Cell Proliferation in Chronic Helicobacter pylori Positive Gastritis and Gastric Carcinoma – Correlation between Immuno-Histochemistry and Tv Image Cytometry , 2000, Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology.
[51] E. Kliewer,et al. Seroprevalence of Helicobacter pylori, Incidence of Gastric Cancer, and Peptic Ulcer-Associated Hospitalizations in a Canadian Indian Population , 1999, Digestive Diseases and Sciences.
[52] N. Talley,et al. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. , 1997, The American journal of gastroenterology.
[53] D. Ahlquist,et al. Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. , 1997, JAMA.
[54] J. H. Baron,et al. Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection , 1997, BMJ.
[55] Douglas K Owens,et al. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials , 1996, The Lancet.
[56] C. Lamers,et al. Seroepidemiology of gastritis in Japanese and Dutch male employees with and without ulcer disease , 1996, European journal of gastroenterology & hepatology.
[57] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[58] B. Collins,et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up , 1994, The Lancet.
[59] P. Sherman,et al. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[60] E Hentschel,et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. , 1993, The New England journal of medicine.
[61] T. Dragani,et al. Libri Ricevuti: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1992 .
[62] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[63] D. Graham,et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. , 1991, Digestive diseases and sciences.
[64] Alter Mj,et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.
[65] D. Graham,et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. , 1991, Gastroenterology.
[66] J. Samet,et al. Stomach cancer among New Mexico's American Indians, Hispanic whites, and non-Hispanic whites. , 1989, Cancer research.
[67] S. Zenios,et al. An empiric estimate of the value of life: updating the renal dialysis cost-effectiveness standard. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[68] M. Ezzati,et al. Exploring the cost‐effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results , 2009, International journal of cancer.
[69] C. Bernstein,et al. Helicobacter pylori in the Canadian arctic: seroprevalence and detection in community water samples , 1999, American Journal of Gastroenterology.
[70] Y. Nikitin,et al. Helicobacter pylori in a Chukotka Native male population. , 1998, International journal of circumpolar health.
[71] E. El-Omar,et al. Interactions between H. pylori infection, gastric acid secretion and anti-secretory therapy. , 1998, British medical bulletin.
[72] R. Hunt,et al. Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology. , 1998, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[73] E. Kuipers,et al. The prevalence of Helicobacter pylori in peptic ulcer disease. , 1995, Alimentary pharmacology & therapeutics.
[74] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.